BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37131085)

  • 1. ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification.
    Ye W; Wang J; Huang J; He X; Ma Z; Li X; Huang X; Li F; Huang S; Pan J; Jin J; Ling Q; Wang Y; Yu Y; Sun J; Jin J
    Front Med; 2023 Aug; 17(4):685-698. PubMed ID: 37131085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating effects of acyl-CoA synthetase 5-derived mitochondrial Wnt2B palmitoylation on intestinal Wnt activity.
    Klaus C; Schneider U; Hedberg C; Schütz AK; Bernhagen J; Waldmann H; Gassler N; Kaemmerer E
    World J Gastroenterol; 2014 Oct; 20(40):14855-64. PubMed ID: 25356045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
    Xiao Y; Deng T; Ming X; Xu J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
    Zhai H; Zhao J; Pu J; Zhao P; Wei J
    Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
    Mashima T; Sato S; Sugimoto Y; Tsuruo T; Seimiya H
    Oncogene; 2009 Jan; 28(1):9-19. PubMed ID: 18806831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
    Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
    World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
    Li C; Xin H; Shi Y; Mu J
    Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
    Xin H; Li C; Wang M
    Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
    Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
    Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
    Bu SY; Mashek DG
    J Lipid Res; 2010 Nov; 51(11):3270-80. PubMed ID: 20798351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway.
    Li C; Wang M; Shi Y; Xin H
    Environ Toxicol; 2022 Aug; 37(8):1934-1943. PubMed ID: 35442555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis.
    Reinartz A; Ehling J; Leue A; Liedtke C; Schneider U; Kopitz J; Weiss T; Hellerbrand C; Weiskirchen R; Knüchel R; Gassler N
    Biochim Biophys Acta; 2010 Sep; 1801(9):1025-35. PubMed ID: 20470896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
    Mashima T; Sato S; Okabe S; Miyata S; Matsuura M; Sugimoto Y; Tsuruo T; Seimiya H
    Cancer Sci; 2009 Aug; 100(8):1556-62. PubMed ID: 19459852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dipeptide type inhibitor of the Wnt/β-catenin pathway suppresses proliferation of acute myelogenous leukemia cells.
    Wakabayashi R; Hattori Y; Hosogi S; Toda Y; Takata K; Ashihara E
    Biochem Biophys Res Commun; 2021 Jan; 535():73-79. PubMed ID: 33341676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
    Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N
    Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
    Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
    J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
    Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL
    Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.